SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950162-07-000698
Filing Date
2007-11-23
Accepted
2007-11-23 15:37:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 PAOLO CAVAZZA/SCICLONE SCHEDULE 13D - 11/13/07 paolosci13d_111307.htm SC 13D 64146
2 EXHIBIT 1 ex1.htm EX-1 55175
  Complete submission text file 0000950162-07-000698.txt   121072
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-43408 | Film No.: 071264978
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA TESSERETE, 10 LUGANO V8 V8
Business Address VIA SUDAFRICA, 20 ROME A1 00000
CAVAZZA PAOLO (Filed by) CIK: 0001163608 (see all company filings)

Type: SC 13D